Neoadjuvant chemotherapy for advanced gastric cancer: A meta-analysis

doi:10.3748/wjg.v16.i44.5621

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 44

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5336)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-2) series.

Item

Count

PDF

509

HTML

4556

Figures (1-3)

132

Tables (1-2)

139

Sum=5336

Nov 28, 2010 (publication date) through Apr 26, 2024

Times Cited of This Article

Times Cited (79)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Nov 28, 2010; 16(44): 5621-5628
Published online Nov 28, 2010. doi: 10.3748/wjg.v16.i44.5621

Full Size Figure Download Figure

Figure 1 Overall survival rates of patients with advanced gastric cancer in 12 studies (A), 3-year progression-free rates in 3 studies (B), tomor down-staging rates in 6 studies (C), R0 resection rates in 8 studies (D), and adverse effects of neoadjuvant chemotherapy (E). NAC: Neoadjuvant chemotherapy; PFS: Progression-free survival; CI: Confidence interval.

Citation: Li W, Qin J, Sun YH, Liu TS. Neoadjuvant chemotherapy for advanced gastric cancer: A meta-analysis. World J Gastroenterol 2010; 16(44): 5621-5628
URL: https://www.wjgnet.com/1007-9327/full/v16/i44/5621.htm
DOI: https://dx.doi.org/10.3748/wjg.v16.i44.5621